Letters to the Editor
Early Access
Free access to medications for scabies treatment in Italy: a call to action and the need to evaluate its clinical and epidemiological impact
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 18 March 2026
120
Views
77
Downloads
Authors
Dear Editor,
The escalating spread of scabies, caused by the Sarcoptes scabiei mite, is a pressing and worrisome public health concern, with increasing worldwide incidence every year and frequent outbreaks, making it not only an Italian problem but a global one. The World Health Organization (WHO) has identified several key actions to control scabies, the most significant being the provision of funded therapies and their integration into universal health coverage programs. [...]
Downloads
Download data is not yet available.
Citations
1. Donà MG, Giuliani E, Giglio A, et al. Increasing trend in confirmed scabies cases in the only public dermatological institute of scientific research and care in Italy. Eur J Dermatol 2023;33:709-10.
2. El-Moamly AA. Scabies as a part of the World Health Organization roadmap for neglected tropical diseases 2021-2030: what we know and what we need to do for global control. Trop Med Health 2021;49:64.
3. Mbuagbaw L, Sadeghirad B, Morgan RL, et al. Failure of scabies treatment: a systematic review and meta-analysis. Br J Dermatol 2024;190:163-73.
4. Neri I, Mussi M, Robuffo S, et al. Scabies severity score: the key to predicting and preventing treatment failures? Clin Exp Dermatol 2025;50:1446-7.
5. Heukelbach J, Mazigo HD, Ugbomoiko US. Impact of scabies in resource-poor communities. Curr Opin Infect Dis 2013;26:127-32.
6. Zengarini C, Mussi M, La Placa M, et al. Scabies increasing incidence in Bologna from 2013 to 2024: a retrospective analysis. Sex Transm Infect 2025;101:256-8.
How to Cite
1.
Zengarini C, Mussi M, Neri I, Gaspari V, Piraccini BM, Rech G, et al. Free access to medications for scabies treatment in Italy: a call to action and the need to evaluate its clinical and epidemiological impact. Dermatol Reports [Internet]. 2026 Mar. 18 [cited 2026 Apr. 18];. Available from: https://journals.pagepress.net/dr/article/view/10323
Copyright (c) 2026 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
